Related Experiment Video
Updated: Dec 5, 2025
06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
684
Medical therapy versus TEVAR for uncomplicated type B aortic dissection
Varinder Singh Bedi1, Pranati Swain2, Ajay Yadav1
1Institute of Vascular & Endovascular Sciences, Sir Ganga Ram Hospital, New Delhi, Delhi 110060 India.
Indian Journal of Thoracic and Cardiovascular Surgery
|October 16, 2020
Summary
Optimal medical management is standard for uncomplicated acute type B aortic dissection (uTBAD). However, thoracic endovascular aortic repair (TEVAR) shows promise for select patients, shifting treatment approaches.
Area of Science:
- Cardiovascular Surgery
- Vascular Medicine
- Medical Interventions
Background:
- Optimal medical management has been the standard for uncomplicated acute type B aortic dissection (uTBAD).
- Surgical and endovascular interventions are typically reserved for complicated cases.
- Recent data suggest potential long-term complications with medical management alone.
Purpose of the Study:
- To evaluate the evolving role of thoracic endovascular aortic repair (TEVAR) in uncomplicated acute type B aortic dissection (uTBAD).
- To assess the shift in treatment paradigms driven by increased TEVAR safety and new long-term data.
Main Methods:
- Review of current treatment standards for uTBAD.
- Analysis of recent data on TEVAR safety and efficacy.
- Evaluation of long-term outcomes for medical management versus intervention.
Main Results:
- Increasing confidence and safety in thoracic endovascular aortic repair (TEVAR).
- Emerging data highlight potential long-term complications associated with optimal medical management for uTBAD.
- Thoracic endovascular aortic repair (TEVAR) remains controversial but offers benefits for a specific patient subset.
Conclusions:
- A shift in treatment approach for uTBAD is occurring, considering TEVAR.
- While controversial, TEVAR is beneficial for a subset of patients with uTBAD.
- Further research is needed to define the optimal role of TEVAR in uTBAD management.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
210
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
210
01:26Aneurysm III: Interprofessional Care
145
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
145
01:26Mitral Stenosis III: Medical Management
146
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
146
01:29Venous Thrombosis III: Interprofessional Care
167
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
167
01:25Mitral Regurgitation III: Medical Management
157
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
157